Gender identity and lifetime prevalence of skin cancer in the United States
JAMA Dermatology Feb 20, 2020
Singer S, et al. - In view of an increasing national focus on investigating cancer risks of transgender and gender-nonconforming patients and, despite prior research investigating skin cancer prevalence among sexual minority populations, researchers undertook the first study evaluating skin cancer history by gender identity. One’s personal sense of gender is referred as gender identity; it includes recognizing as cisgender (ie, a gender identity that aligns with the gender assigned at birth), transgender (ie, a gender identity that does not align with the gender assigned at birth), and gender nonconforming (ie, a gender identity that does not follow others’ ideas about how a person should look or act based on the gender assigned at birth).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries